Good quality of life in former Buruli ulcer patients with small lesions: long-term follow-up of the BURULICO trial.

Buruli Ulcer is a tropical skin disease caused by Mycobacterium ulcerans, which, due to scarring and contractures can lead to stigma and functional limitations. However, recent advances in treatment, combined with increased public health efforts have the potential to significantly improve disease ou...

Full description

Bibliographic Details
Main Authors: Sandor Klis, Adelita Ranchor, Richard O Phillips, Kabiru M Abass, Wilson Tuah, Susanne Loth, Kristien Velding, Tjip S van der Werf, Ymkje Stienstra
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-07-01
Series:PLoS Neglected Tropical Diseases
Online Access:http://europepmc.org/articles/PMC4091870?pdf=render
id doaj-5506cc0bc013428bbe5d15454b248cec
record_format Article
spelling doaj-5506cc0bc013428bbe5d15454b248cec2020-11-24T23:57:12ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352014-07-0187e296410.1371/journal.pntd.0002964Good quality of life in former Buruli ulcer patients with small lesions: long-term follow-up of the BURULICO trial.Sandor KlisAdelita RanchorRichard O PhillipsKabiru M AbassWilson TuahSusanne LothKristien VeldingTjip S van der WerfYmkje StienstraBuruli Ulcer is a tropical skin disease caused by Mycobacterium ulcerans, which, due to scarring and contractures can lead to stigma and functional limitations. However, recent advances in treatment, combined with increased public health efforts have the potential to significantly improve disease outcome.To study the Quality of Life (QoL) of former Buruli Ulcer patients who, in the context of a randomized controlled trial, reported early with small lesions (cross-sectional diameter <10 cm), and received a full course of antibiotic treatment.127 Participants of the BURULICO drug trial in Ghana were revisited. All former patients aged 16 or older completed the Dermatology Life Quality Index (DLQI) and the abbreviated World Health Organization Quality of Life scale (WHOQOL-BREF). The WHOQOL-BREF was also administered to 82 matched healthy controls. Those younger than 16 completed the Childrens' Dermatology Life Quality Index (CDLQI) only.The median (Inter Quartile Range) score on the DLQI was 0 (0-4), indicating good QoL. 85% of former patients indicated no effect, or only a small effect of the disease on their current life. Former patients also indicated good QoL on the physical and psychological domains of the WHOQOL-BREF, and scored significantly higher than healthy controls on these domains. There was a weak correlation between the DLQI and scar size (ρ = 0.32; p<0.001).BU patients who report early with small lesions and receive 8 weeks of antimicrobial therapy have a good QoL at long-term follow-up. These findings contrast with the debilitating sequelae often reported in BU, and highlight the importance of early case detection.http://europepmc.org/articles/PMC4091870?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Sandor Klis
Adelita Ranchor
Richard O Phillips
Kabiru M Abass
Wilson Tuah
Susanne Loth
Kristien Velding
Tjip S van der Werf
Ymkje Stienstra
spellingShingle Sandor Klis
Adelita Ranchor
Richard O Phillips
Kabiru M Abass
Wilson Tuah
Susanne Loth
Kristien Velding
Tjip S van der Werf
Ymkje Stienstra
Good quality of life in former Buruli ulcer patients with small lesions: long-term follow-up of the BURULICO trial.
PLoS Neglected Tropical Diseases
author_facet Sandor Klis
Adelita Ranchor
Richard O Phillips
Kabiru M Abass
Wilson Tuah
Susanne Loth
Kristien Velding
Tjip S van der Werf
Ymkje Stienstra
author_sort Sandor Klis
title Good quality of life in former Buruli ulcer patients with small lesions: long-term follow-up of the BURULICO trial.
title_short Good quality of life in former Buruli ulcer patients with small lesions: long-term follow-up of the BURULICO trial.
title_full Good quality of life in former Buruli ulcer patients with small lesions: long-term follow-up of the BURULICO trial.
title_fullStr Good quality of life in former Buruli ulcer patients with small lesions: long-term follow-up of the BURULICO trial.
title_full_unstemmed Good quality of life in former Buruli ulcer patients with small lesions: long-term follow-up of the BURULICO trial.
title_sort good quality of life in former buruli ulcer patients with small lesions: long-term follow-up of the burulico trial.
publisher Public Library of Science (PLoS)
series PLoS Neglected Tropical Diseases
issn 1935-2727
1935-2735
publishDate 2014-07-01
description Buruli Ulcer is a tropical skin disease caused by Mycobacterium ulcerans, which, due to scarring and contractures can lead to stigma and functional limitations. However, recent advances in treatment, combined with increased public health efforts have the potential to significantly improve disease outcome.To study the Quality of Life (QoL) of former Buruli Ulcer patients who, in the context of a randomized controlled trial, reported early with small lesions (cross-sectional diameter <10 cm), and received a full course of antibiotic treatment.127 Participants of the BURULICO drug trial in Ghana were revisited. All former patients aged 16 or older completed the Dermatology Life Quality Index (DLQI) and the abbreviated World Health Organization Quality of Life scale (WHOQOL-BREF). The WHOQOL-BREF was also administered to 82 matched healthy controls. Those younger than 16 completed the Childrens' Dermatology Life Quality Index (CDLQI) only.The median (Inter Quartile Range) score on the DLQI was 0 (0-4), indicating good QoL. 85% of former patients indicated no effect, or only a small effect of the disease on their current life. Former patients also indicated good QoL on the physical and psychological domains of the WHOQOL-BREF, and scored significantly higher than healthy controls on these domains. There was a weak correlation between the DLQI and scar size (ρ = 0.32; p<0.001).BU patients who report early with small lesions and receive 8 weeks of antimicrobial therapy have a good QoL at long-term follow-up. These findings contrast with the debilitating sequelae often reported in BU, and highlight the importance of early case detection.
url http://europepmc.org/articles/PMC4091870?pdf=render
work_keys_str_mv AT sandorklis goodqualityoflifeinformerburuliulcerpatientswithsmalllesionslongtermfollowupoftheburulicotrial
AT adelitaranchor goodqualityoflifeinformerburuliulcerpatientswithsmalllesionslongtermfollowupoftheburulicotrial
AT richardophillips goodqualityoflifeinformerburuliulcerpatientswithsmalllesionslongtermfollowupoftheburulicotrial
AT kabirumabass goodqualityoflifeinformerburuliulcerpatientswithsmalllesionslongtermfollowupoftheburulicotrial
AT wilsontuah goodqualityoflifeinformerburuliulcerpatientswithsmalllesionslongtermfollowupoftheburulicotrial
AT susanneloth goodqualityoflifeinformerburuliulcerpatientswithsmalllesionslongtermfollowupoftheburulicotrial
AT kristienvelding goodqualityoflifeinformerburuliulcerpatientswithsmalllesionslongtermfollowupoftheburulicotrial
AT tjipsvanderwerf goodqualityoflifeinformerburuliulcerpatientswithsmalllesionslongtermfollowupoftheburulicotrial
AT ymkjestienstra goodqualityoflifeinformerburuliulcerpatientswithsmalllesionslongtermfollowupoftheburulicotrial
_version_ 1725455030060843008